骶神经与经皮胫神经调节治疗非神经源性下尿路功能障碍及慢性盆腔疼痛的系统综述
该系统综述评估骶神经调节(SNM)与经皮胫神经刺激(PTNS)治疗保守治疗无效的非神经源性下尿路功能障碍的疗效与安全性。PTNS成功/改善率54%-59%。两种技术对间质性膀胱炎/膀胱疼痛综合征的疗效较低,PTNS副作用更少但缺乏长期验证。
要点
- SNM对膀胱过度活动症或慢性非梗阻性尿潴留疗效持久且安全。
- PTNS短期成功率高、副作用少,但长期疗效未证实。
- 间质性膀胱炎/膀胱疼痛综合征患者疗效低于其他适应证。
核心结论
- 神经调节对保守治疗无效的膀胱过度活动症或慢性非梗阻性尿潴留患者有效且安全,疗效持久。
- PTNS成功率高且副作用少于SNM,但需长期随访确认。
研究设计与样本
- 系统综述,检索PubMed/Medline和Scopus,限定1998年1月至2017年6月发表的英文文献。
主要发现
- SNM漏尿发作改善≥50%的比例范围为29%至76%。
- SNM总体干率范围为43%至56%。
- PTNS总体成功/改善率范围为54%至59%。
- 间质性膀胱炎/膀胱疼痛综合征患者症状改善或疗效在两种技术中均低于其他适应证。
- PTNS患者副作用少于SNM患者。
临床怎么用
- 对保守治疗无效的非神经源性下尿路功能障碍患者可考虑SNM或PTNS。
- 选择PTNS时需告知患者短期有效、副作用少但长期疗效未证实。
局限性
- PTNS缺乏长期随访数据。
- 间质性膀胱炎/膀胱疼痛综合征患者疗效较低需注意。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Neuromodulation is considered in patients with non-neurogenic lower urinary tract dysfunction (LUTD) not responsive to conservative treatment. OBJECTIVE: To systematically review the available studies on efficacy and safety of sacral neuromodulation (SNM) and percutaneous tibial nerve stimulation (PTNS) in non-neurogenic LUTDs not responsive to conservative treatments. EVIDENCE ACQUISITION: A literature research was conducted in PubMed/Medline and Scopus, restricted to articles in English, published between January 1998 and June 2017, with at least 20 patients and 6 mo of follow-up. EVIDENCE SYNTHESIS: Twenty-one reports were identified. Concerning SNM, the improvement of ≥50% in leakage episodes ranged widely between 29% and 76%. Overall dry rate ranged between 43% and 56%. Overall success/improvement rate in PTNS varied between 54% and 59%. Symptom improvement or efficacy in interstitial cystitis/bladder pain syndrome patients appeared to be lower compared with other indications in both techniques. Safety data showed fewer side effects in patients submitted to PTNS. CONCLUSIONS: Neuromodulation gives good results and is a safe therapy for patients with overactive bladder or chronic nonobstructive urinary retention with long-lasting efficacy. Moreover, PTNS has been shown to have good success rates and fewer side effects compared with SNM. These data have to be confirmed with long-term follow-up. PATIENT SUMMARY: Sacral neuromodulation can improve low urinary tract symptoms in selected patients; it appears to be a safe therapy for nonresponders to standard medical therapies. Percutaneous tibial nerve stimulation (PTNS) is a less invasive technique that gives good results in short time with fewer side effects. However, we must consider that PTNS has not been tested in the long term and results are lower if compared with SNM.
引用
- Tutolo M, Ammirati E, Heesakkers J, et al. Efficacy and Safety of Sacral and Percutaneous Tibial Neuromodulation in Non-neurogenic Lower Urinary Tract Dysfunction and Chronic Pelvic Pain: A Systematic Review of the Literature. Eur Urol. 2018. PMID: 29336927. doi:10.1016/j.eururo.2017.11.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。